Does cotrimoxazole prophylaxis in HIV patients increase the drug resistance of pneumococci? A comparative cross-sectional study in southern Ethiopia.

Does cotrimoxazole prophylaxis in HIV patients increase the drug resistance of pneumococci? A comparative cross-sectional study in southern Ethiopia.

<h4>Background</h4>Infections caused by antibiotic-resistant bacteria results in high rates of morbidity and mortality. Although the prolonged cotrimoxazole (CTX) prophylaxis is arguably associated with the risk of increasing drug resistance in the common pathogens, information regarding...

Full description

Bibliographic Details
Main Authors:	Mohammed Seid, Getnet Beyene, Yared Alemu, Bereket Workalemahu, Mulugeta Delbo, Dagimawie Taddesse, Gelila Biresaw, Aseer Manilal
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0243054

Similar Items

Magnitude and associated factors of bacterial urinary tract infections among paediatric patients in Arba Minch, southern Ethiopia
by: Ali Kedir Elale, et al.
Published: (2023-01-01)

Indoor air microbial load, antibiotic susceptibility profiles of bacteria, and associated factors in different wards of Arba Minch General Hospital, southern Ethiopia.
by: Gebre Kayta, et al.
Published: (2022-01-01)

Bacteriological quality and safety of bottle food and associated factors among bottle-fed babies attending pediatric outpatient clinics of Government Health Institutions in Arba Minch, southern Ethiopia
by: Alebachew Marege, et al.
Published: (2023-05-01)

Cotrimoxazole prophylaxis for infants exposed to HIV infection
by: Stephen M. Graham

Cotrimoxazole prophylaxis for infants exposed to HIV infection
by: Stephen M. Graham
Published: (2004-04-01)

Bacteriological quality and antimicrobial susceptibility profiles of isolates of ready-to-eat raw minced meat from hotels and restaurants in Arba Minch, Ethiopia.
by: Tomas Tonjo, et al.
Published: (2022-01-01)

Ethno-pharmacological investigations of Moringa stenopetala Bak. Cuf. and its production challenges in southern Ethiopia.
by: Azene Tesfaye, et al.
Published: (2022-01-01)

The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
by: Ryan, M, et al.
Published: (2008)

Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China
by: Wei Cheng, et al.

Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection
by: Gill Christopher J., et al.
Published: (2004-01-01)

Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV.
by: Christopher J Hoffmann, et al.
Published: (2014-01-01)

Catheter-Associated Urinary Tract Infection: Incidence, Associated Factors and Drug Resistance Patterns of Bacterial Isolates in Southern Ethiopia
by: Oumer Y, et al.
Published: (2021-07-01)

High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study.
by: Yihun Mulugeta Alemu, et al.
Published: (2016-01-01)

Eligibility for cotrimoxazole prophylaxis among adult HIVinfected patients in South Africa
by: S Takuva, et al.
Published: (2019-04-01)

Prevalence, severity and associated risk factors of anemia among human immunodeficiency virus-infected adults in Sawla General Hospital, Southern Ethiopia: A facility-based cross-sectional study
by: Rishan Hadgu, et al.
Published: (2023-01-01)

Methicillin-resistant Staphylococcus aureus colonization among medicine and health science students, Arba Minch University, Ethiopia
by: Ermiyas Mekuriya, et al.
Published: (2022-06-01)

Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
by: Prendergast, A, et al.
Published: (2011)

Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries?
by: Anna Coutsoudis, et al.
Published: (2010-12-01)

Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries?
by: Anna Coutsoudis, et al.

Factors associated with coverage of cotrimoxazole prophylaxis in HIV-exposed children in South Africa.
by: Dhayendre Moodley, et al.
Published: (2013-01-01)

Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.
by: Neeraj Raizada, et al.
Published: (2009-06-01)

Utilization of companionship during delivery and associated factors among women who gave birth at Arba Minch town public health facilities, southern Ethiopia.
by: Kassaw Beyene Getahun, et al.
Published: (2020-01-01)

Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.
by: Scott Dryden-Peterson, et al.
Published: (2013-01-01)

Burden of hepatitis B surface antigen sero-prevalence and associated factors among pregnant women receiving antenatal care at a public health institution, southern Ethiopia, 2018: implications for public health prevention
by: Tinsae Marama, et al.
Published: (2020-12-01)

Utilization of companionship during delivery and associated factors among women who gave birth at Arba Minch town public health facilities, southern Ethiopia
by: Kassaw Beyene Getahun, et al.
Published: (2020-01-01)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
by: Prendergast, A, et al.
Published: (2016)

The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
by: Walker, A, et al.
Published: (2007)

Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi
by: Mwaungulu Frank B.D., et al.
Published: (2004-01-01)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
by: Chishinga Nathaniel, et al.
Published: (2011-06-01)

Magnitude and antimicrobial susceptibility profiles of Gram-Negative bacterial isolates among patients suspected of urinary tract infections in Arba Minch General Hospital, southern Ethiopia.
by: Asaye Mitiku, et al.
Published: (2022-01-01)

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
by: Dennis W Juma, et al.
Published: (2019-03-01)

Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.
by: Dean B Everett, et al.
Published: (2011-03-01)

The complexity of serotype replacement of pneumococci
by: Orsolya Dobay
Published: (2019-11-01)

Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda.
by: Philip Orishaba, et al.
Published: (2020-01-01)

Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine
by: Guro K. Bårnes, et al.
Published: (2016-11-01)

Knowledge of oral health during pregnancy and associated factors among pregnant mothers attending antenatal care at South Omo Zone public hospitals, Southern Ethiopia, 2021
by: Biresaw Wassihun, et al.
Published: (2022-01-01)

Knowledge of oral health during pregnancy and associated factors among pregnant mothers attending antenatal care at South Omo Zone public hospitals, Southern Ethiopia, 2021.
by: Biresaw Wassihun, et al.
Published: (2022-01-01)

Potential in vitro antimicrobial efficacy of Holigarna arnottiana (Hook F)
by: Aseer Manilal, et al.
Published: (2014-01-01)

Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study
by: Junjun Jiang, et al.
Published: (2019-01-01)

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial.
by: Christina S Polyak, et al.
Published: (2016-01-01)